TY - JOUR
T1 - Efficient genetic engineering of human intestinal organoids using electroporation
AU - Fujii, Masayuki
AU - Matano, Mami
AU - Nanki, Kosaku
AU - Sato, Toshiro
N1 - Funding Information:
acknoWleDGMents This work was supported by grants from a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), by a Grant-in-Aid for Scientific Research on Innovative Areas ‘Stem Cell Aging and Disease’ and by Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology of Japan. L-Wnt3A cells and the R-spondin1–producing cell line were kindly gifted by H. Clevers (Hubrecht Institute) and C. Kuo (Stanford University), respectively.
Publisher Copyright:
© 2015 Nature America, Inc. All rights reserved.
PY - 2015/10/29
Y1 - 2015/10/29
N2 - Gene modification in untransformed human intestinal cells is an attractive approach for studying gene function in intestinal diseases. However, because of the lack of practical tools, such studies have largely depended upon surrogates, such as gene-engineered mice or immortalized human cell lines. By taking advantage of the recently developed intestinal organoid culture method, we developed a methodology for modulating genes of interest in untransformed human colonic organoids via electroporation of gene vectors. Here we describe a detailed protocol for the generation of intestinal organoids by culture with essential growth factors in a basement membrane matrix. We also describe how to stably integrate genes via the piggyBac transposon, as well as precise genome editing using the CRISPR-Cas9 system. Beginning with crypt isolation from a human colon sample, genetically modified organoids can be obtained in 3 weeks.
AB - Gene modification in untransformed human intestinal cells is an attractive approach for studying gene function in intestinal diseases. However, because of the lack of practical tools, such studies have largely depended upon surrogates, such as gene-engineered mice or immortalized human cell lines. By taking advantage of the recently developed intestinal organoid culture method, we developed a methodology for modulating genes of interest in untransformed human colonic organoids via electroporation of gene vectors. Here we describe a detailed protocol for the generation of intestinal organoids by culture with essential growth factors in a basement membrane matrix. We also describe how to stably integrate genes via the piggyBac transposon, as well as precise genome editing using the CRISPR-Cas9 system. Beginning with crypt isolation from a human colon sample, genetically modified organoids can be obtained in 3 weeks.
UR - http://www.scopus.com/inward/record.url?scp=84942524980&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942524980&partnerID=8YFLogxK
U2 - 10.1038/nprot.2015.088
DO - 10.1038/nprot.2015.088
M3 - Article
C2 - 26334867
AN - SCOPUS:84942524980
SN - 1754-2189
VL - 10
SP - 1474
EP - 1485
JO - Nature Protocols
JF - Nature Protocols
IS - 10
ER -